1. Home
  2. CANF vs CNVS Comparison

CANF vs CNVS Comparison

Compare CANF & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.22

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.35

Market Cap

65.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CANF
CNVS
Founded
1994
2000
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Video Chains
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
65.5M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
CANF
CNVS
Price
$3.22
$2.35
Analyst Decision
Strong Buy
Buy
Analyst Count
2
1
Target Price
$9,750.00
$9.00
AVG Volume (30 Days)
613.1K
128.9K
Earning Date
03-26-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
108.99
EPS
N/A
N/A
Revenue
N/A
$78,181,000.00
Revenue This Year
$461.72
N/A
Revenue Next Year
$290,391.28
$84.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
59.13
52 Week Low
$0.17
$1.77
52 Week High
$10.40
$7.39

Technical Indicators

Market Signals
Indicator
CANF
CNVS
Relative Strength Index (RSI) 37.97 41.79
Support Level $0.59 $2.34
Resistance Level $4.74 $2.47
Average True Range (ATR) 0.20 0.17
MACD -0.08 -0.06
Stochastic Oscillator 8.07 12.99

Price Performance

Historical Comparison
CANF
CNVS

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

Share on Social Networks: